Patient Management

In a recent review, researchers examined the molecular and clinical effects of glucagon-like peptide 1 (GLP-1) receptor agonists in treating metabolic dysfunction-associated steatotic liver disease (SLD)....

Patient Management Guidelines

Guidance From Medscape

Expert opinions, case studies, quizzes, and more can be found at Medscape’s new portal for clinicians who treat metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis.

Managing Metabolic Dysfunction-associated Steatotic Liver and Metabolic Dysfunction-associated Steatohepatitis

The Journal of Hepatology provides detailed information for clinicians who treat patients who have been diagnosed with liver diseases formerly known as nonalcoholic steatohepatitis (NASH).

American Association for the Study of Liver Diseases (AASLD) Guidelines

AASLD offers guidelines that are current and revised regularly by a committee of experts in the field of hepatology.

Articles

MASLD: The Growing Need for Early Intervention

MASLD (metabolic-associated steatotic liver disease) is the most common chronic liver disease in the US, affecting an estimated 31% of...
Corrie Berk,
CURATED BY:
Corrie Berk,
DNP, MBA, APRN

Refining NAFLD Thresholds: Insights on Liver Fat and Metabolic Health

Recent research highlights the challenge of defining excess intrahepatic triglyceride (IHTG) levels in nonalcoholic fatty liver disease (NAFLD), emphasizing the...
Miu Lai (Milly) Ng,
CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Obesity and Alcohol Synergistically Increase Liver Cancer Risk in Hepatitis B-Positive Men

A 14-year prospective study of 2,260 Taiwanese men from the REVEAL-HBV cohort investigated the combined effects of body mass index...
Miu Lai (Milly) Ng,
CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Rising Obesity and Diabetes Drive Global Surge in NAFLD, Highlighting Need for Better Treatments

As obesity and type 2 diabetes continue to rise globally, the prevalence of non-alcoholic fatty liver disease (NAFLD) is also...
Corrie Berk,
CURATED BY:
Corrie Berk,
DNP, MBA, APRN

NAFLD Affects 37% of US Adults, Driving New Care Pathway for Better Screening and Treatment

Nonalcoholic fatty liver disease (NAFLD) affects about 37% of adults in the United States and up to 70% of individuals...
Chantil D. Jeffreys,
CURATED BY:
Chantil D. Jeffreys,
FNP, DNP, JD

Alcohol and Metabolic Syndrome: A Synergistic Risk for Chronic Liver Disease

Alcohol use and metabolic syndrome (MetS) are both highly prevalent and often co-exist, contributing independently and synergistically to chronic liver...
Miu Lai (Milly) Ng,
CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)
Share